After FDA setback, PTC Therapeutics' DMD drug Translarna faces possible market withdrawal in Europe

After FDA setback, PTC Therapeutics' DMD drug Translarna faces possible market withdrawal in Europe

Submitted by admin on September 15, 2023 - 11:49am
Source: 
Fierce Pharma
News Tags: 
PTC Therapeutics
DMD
Translarna
Europe
Headline: 
After FDA setback, PTC Therapeutics' DMD drug Translarna faces possible market withdrawal in Europe
snippet: 

A “surprised and extremely disappointed” PTC Therapeutics is scrambling to keep its Duchenne muscular dystrophy therapy Translarna on the European market after a detrimental review.

Do Not Allow Advertisers to Use My Personal information